Novo Nordisk A/S (NVO)
50.18
-0.11
(-0.22%)
USD |
NYSE |
Dec 12, 16:00
50.33
+0.15
(+0.30%)
After-Hours: 20:00
Novo Nordisk Free Cash Flow: 9.245B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Evaxion AS | -- |
| Ascendis Pharma A/S | -123.89M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Omeros Corp. | -105.32M |
| Viking Therapeutics, Inc. | -224.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.308B |
| Cash from Investing (Quarterly) | -2.440B |
| Cash from Financing (Quarterly) | -2.797B |
| Free Cash Flow Per Share (Quarterly) | 1.083 |
| Free Cash Flow to Equity (Quarterly) | 4.503B |
| Free Cash Flow to Firm (Quarterly) | 4.817B |
| Free Cash Flow Yield | 4.14% |